An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder.
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
Exxon Mobil Corporation’s XOM acquisition of Pioneer Natural Resources was given the final approval by the U.S. regulatory body, the Federal Trade Commission (“FTC”), on Jan. 17, 2025. In the same ...